Nitric oxide plays a key role in myelination in the developing brain

Journal of Neuropathology and Experimental Neurology

Volumn 69, Issue 8, 2010, Pages 828-837

  Olivier, Paul ^a,b   Loron, Gauthier ^a,b   Fontaine, Romain H ^a,b   Pansiot, Julien ^a,b   Dalous, Jérémie ^a,b,e   Thi, Hoa Pham ^a,b   Charriaut Marlangue, Christiane ^a,b   Thomas, Jean Léon ^c   Mercier, Jean Christophe ^d   Gressens, Pierre ^b,e   Baud, Olivier ^a,b,e  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e PremUP   (France)

Author keywords

Brain damage; Development; Myelination; Nitric oxide; Prematurity; Repair

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BIRTH; BRAIN DAMAGE; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; MOUSE; MYELINATION; NEUROPROTECTION; NEWBORN PERIOD; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; RODENT; WHITE MATTER;

ADMINISTRATION, INHALATION; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS; BEHAVIORAL SYMPTOMS; BRAIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; FEMALE; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; NERVE FIBERS, MYELINATED; NERVE TISSUE PROTEINS; NEURONS; NEUROPSYCHOLOGICAL TESTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; O ANTIGENS; OLIGODENDROGLIA; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; SPACE PERCEPTION; SPATIAL BEHAVIOR; STATISTICS, NONPARAMETRIC;

EID: 77955468891     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181ea5203     Document Type: Article

References (45)

1. Larroque B,Ancel PY,Marret S, et al. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): A longitudinal cohort study. Lancet 2008;371:813-820
2. Marlow N, Wolke D, Bracewell MA, et al. EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005;352:9-19
3. Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 2008;93:F153-61
4. Bredt DS, Snyder SH. Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 1994;63:175-195
5. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526 (Pubitemid 17085822)
6. Barrington K, Finer N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2006;CD000509
7. Mestan KL, Marks JD, Hecox K, et al. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 2005; 353:23-32
8. Williams A, Piaton G, Aigrot MS, et al. Semaphorin 3A and 3F: Key players in myelin repair in multiple sclerosis? Brain 2007;130:2554-2565
9. Baud O, Daire JL, Dalmaz Y, et al. Gestational hypoxia induces white matter damage in neonatal rats: A new model of periventricular leukomalacia. Brain Pathol 2004;14:1-10
10. Dean JM, Farrag D, Zahkouk SA, et al. Cerebellar white matter injury following systemic endotoxemia in preterm fetal sheep. Neuroscience 2009;160:606-615
11. Fontaine RH, Olivier P, Massonneau V, et al. Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits. Proc Natl Acad Sci\USA 2008; 105:16779-16784
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanateYphenolYchloroform extraction. Anal Biochem 1987;162:156-159
13. Spassky N, de Castro F, Le Bras B, et al. Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J Neurosci 2002;22:5992-6004
14. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996;10:179-190
15. Jing KL, Kim S, Murphy S, et al. Effect of hypoxia and reoxygenation on regional activity of nitric oxide synthase in brain of newborn piglets. Neurosci Lett 1996;206:199-203
16. Kuppusamy P, Ohnishi ST, Numagami Y, et al. Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemiareperfusion. J Cereb Blood Flow Metab 1995;15:899-903
17. Kader A, Frazzini VI, Solomon RA, et al. Nitric oxide production during focal cerebral ischemia in rats. Stroke 1993;24:1709-1716
18. Moro MA, De Alba J, Leza JC, et al. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci 1998;10:445-456
19. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-139
20. Margaill I, Allix M, Boulu RG, et al. Dose-and time-dependence of L-NAME neuroprotection in transient focal ischemia in rats. Br J Pharmacol 1994;651:92-100
21. Li J, Baud O, Vartanian T, et al. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci\USA 2005;102:9936-9941
22. Rosenberg PA, Li Y, Ali S, et al. Intracellular redox state determines whether nitric oxide is toxic or neuroprotective to rat oligodendrocytes in culture. J Neurochem 1999;73:476-484
23. Yamamoto S, Golanov EV, Berger SB, et al. Inhibition of nitric oxide synthase increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 1992;12:717-726
24. Zaharchuk G, Hara H, Huang PL, et al. Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated apparent diffusion coefficient changes in the peri-infarct zone during focal cerebral ischemia. Magn Reson Med 1997;37:170-175
25. Iadecola C, Zhang FY, Casey R, et al. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997;17:9157-9164
26. Rees DD, Palmer RJM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci\USA 1989; 86:3375-3378
27. Chiueh CC. Neuroprotective properties of nitric oxide. Ann N Y Acad Sci 1999;890:301-311
28. Mohanakumar KP, Hanbauer I, Chiueh CC. Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. J Chem Neuroanat 1998;14:195-205
29. Rauhala P, Sziraki I, Chiueh CC. Peroxidation of brain lipids in vitro: Nitric oxide versus hydroxyl radicals. Free Radical Biol Med 1996;21:391-394
30. Rauhala P, Mohanakumar KP, Sziraki I, et al. S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 1996;23:58-60
31. Rauhala P, Lin AM, Chiueh CC. Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 1998;12: 165-173
32. Singh RJ. Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem 1996;271:18596-18603
33. Nikitovic D, Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996;271:19180-19185
34. Gorren AC, Schrammel Astrid, et al. Decomposition of S-nitrosoglutathione in the presence of copper ions and glutathione. Arch Biochem Biophys 1996;330:219-228
35. Radomski MW, Rees DD, Dutra A, et al. S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 1992;107:745-749
36. Konorev EA, Tarpey MM, Joseph J, et al. S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrestVevidence for a cardioprotective effect of nitric oxide. J Pharmacol Exp Ther 1995;274:200-206
37. Konorev EA, Joseph J, Tarpey MM, et al. The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest. Br J Pharmacol 1996;119:511-518
38. Röskam S, Koch M. Effects of neonatal and peripubertal ethanol treatment on various aspects of adult rat behavior and brain anatomy. Int J Dev Neurosci 2009;27:249-256
39. Lutz SE, Zhao Y, Gulinello M, et al. Deletion of astrocyte connexin 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 2009;29:7743-7752
40. Cohen RI, Rottkamp DM, Maric D, et al. A role for semaphorins and neuropilins in oligodendrocyte guidance. J Neurochem 2003;85:1262-1278
41. Worzfeld T, Püschel AW, Offermanns S, et al. Plexin-B family members demonstrate non-redundant expression patterns in the developing mouse nervous system: An anatomical basis for morphogenetic effects of Sema4D during development. Eur J Neurosci 2004;19:2622-2632
42. Worzfeld T, Rauch P, Karram K, et al. Mice lacking Plexin-B3 display normal CNS morphology and behaviour. Mol Cell Neurosci 2009;42: 372-381
43. Castellani V, De Angelis E, Kenwrick S, et al. cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J 2002;21:6348-6357
44. Cheung PY, Salas E, Etches PC, et al. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 1998;351:1181-1182
45. Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial. Lancet 1999;354:1061-65